Question · asked by 0 reviews
RISPERIDONE vs placebo: Leaving the study early
- Population
- patients with schizophrenia
- Intervention
- RISPERIDONE
- Comparison
- placebo
- Outcome
- Leaving the study early
What each review found
Include earlier review versionsNo findings match. Try fewer words or remove a filter.
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- RISPERIDONE vs OLANZAPINE · people with both severe mental illness and substance misuse · 1 review
- RISPERIDONE vs CLOZAPINE ‐ all data short term · people with both severe mental illness and substance misuse · 1 review
- RISPERIDONE vs ZIPRASIDONE ‒ long‐term data (> 12 months) · people with both severe mental illness and substance misuse · 1 review
- RISPERIDONE vs QUETIAPINE · people with both severe mental illness and substance misuse · 1 review
- RISPERIDONE vs PERHENAZINE ‒ long‐term data · people with both severe mental illness and substance misuse · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.